weightwatchers glp-1 program Weight Watchers Weight Watchers Goes All-In on

Explores the potential long-term side effects associated with GLP-1 medications and chronic constipation

The influence of preceding treatment was assessed using propensity score-based inverse probability weighting (PS-IPW)

Interestingly, though products like Ozempic and Mounjaro are indicated for T2D like SGLT2s, the distribution of claims by payer channel differs between the classes

Youve likely heard about glucagon-like peptide-1 agonists commonly referred to as GLP-1 medications, and more widely recognized through pharmaceutical brand names like Ozempic and Mounjaro.

Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent